Trial Search Results

Inflammatory Responses to Acute and Chronic Opioid Exposure in Humans

We aim to examine the extent to which inflammation is affected by acute and chronic opioid exposure.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Drug: Morphine Sulfate

Phase:

N/A

Eligibility


Inclusion Criteria:

   - 18-60 years old

   - Healthy volunteer

   - Not allergic to remifentanil

Exclusion Criteria:

   - Patients younger than 18 or older than 70

   - Patients unwilling or unable to follow study instructions

   - Patients who don't speak English

   - Patients who are taking prescription opioid medications (e.g. vicodin, percocet) or
   are unwilling to refrain from taking anti-inflammatory medications such as Advil or
   Naproxen during 2 weeks prior to and during the 1 month study

Ages Eligible for Study

18 Years - 60 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting